AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CME
  4. [Form 4] CME Group Inc. Insider Trading Activity

[Form 4] CME Group Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

CME Group director Martin J. Gepsman reported an acquisition of 532 shares of Class A Common Stock on June 25, 2025 at a price of $273.03 per share. The shares were granted pursuant to the CME Group Director Stock Plan.

Following this transaction, Gepsman now beneficially owns a total of 25,299 shares directly. The filing indicates this was a standard director compensation grant rather than an open market purchase.

  • Transaction Type: Stock Award (Code A)
  • Ownership Form: Direct
  • Filing Status: Individual filing
  • Role: Director (non-employee)

This insider transaction represents routine director compensation and aligns with standard corporate governance practices for board member equity compensation.

Il direttore di CME Group, Martin J. Gepsman, ha riportato l'acquisizione di 532 azioni di azioni ordinarie di Classe A il 25 giugno 2025 al prezzo di 273,03 $ per azione. Le azioni sono state assegnate in base al Piano Azionario per i Direttori di CME Group.

A seguito di questa operazione, Gepsman possiede ora direttamente un totale di 25.299 azioni. La documentazione indica che si 猫 trattato di una normale assegnazione di compenso per direttori e non di un acquisto sul mercato aperto.

  • Tipo di transazione: Assegnazione di azioni (Codice A)
  • Forma di propriet脿: Diretta
  • Stato della comunicazione: Comunicazione individuale
  • Ruolo: Direttore (non dipendente)

Questa operazione interna rappresenta una compensazione ordinaria per i direttori e rispecchia le pratiche standard di governance aziendale per la remunerazione azionaria dei membri del consiglio.

El director de CME Group, Martin J. Gepsman, inform贸 la adquisici贸n de 532 acciones de acciones ordinarias Clase A el 25 de junio de 2025 a un precio de $273.03 por acci贸n. Las acciones fueron otorgadas conforme al Plan de Acciones para Directores de CME Group.

Tras esta transacci贸n, Gepsman posee ahora directamente un total de 25,299 acciones. El informe indica que se trat贸 de una concesi贸n est谩ndar de compensaci贸n para directores y no de una compra en el mercado abierto.

  • Tipo de transacci贸n: Premio en acciones (C贸digo A)
  • Forma de propiedad: Directa
  • Estado del reporte: Presentaci贸n individual
  • Rol: Director (no empleado)

Esta operaci贸n interna representa una compensaci贸n rutinaria para directores y est谩 en l铆nea con las pr谩cticas est谩ndar de gobernanza corporativa para la remuneraci贸n en acciones de los miembros del consejo.

CME 攴鸽９ 鞚挫偓 Martin J. Gepsman鞚� 2025雲� 6鞗� 25鞚�鞐� 韥措灅鞀� A 氤错喌欤� 532欤�毳� 欤茧嫻 $273.03鞐� 旆摑頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 頃措嫻 欤检嫕鞚� CME 攴鸽９ 鞚挫偓 欤检嫕 瓿勴殟鞐� 霐半澕 攵�鞐悳 瓴冹瀰雼堧嫟.

鞚措矆 瓯半灅 頉� Gepsman鞚� 歆侅爲鞝侅溂搿� 齑� 25,299欤�毳� 氤挫湢頃橁矊 霅橃棃鞀惦媹雼�. 鞝滌稖霅� 靹滊鞐� 霐半ゴ氅� 鞚措姅 瓿店皽 鞁滌灔鞐愳劀鞚� 毵れ垬臧� 鞎勲媽 鞚茧皹鞝侅澑 鞚挫偓 氤挫儊 攵�鞐榾鞀惦媹雼�.

  • 瓯半灅 鞙犿槙: 欤检嫕 氤挫儊 (旖旊摐 A)
  • 靻岇湢 順曧儨: 歆侅爲 氤挫湢
  • 鞁犼碃 靸來儨: 臧滌澑 鞁犼碃
  • 鞐暊: 鞚挫偓 (牍勳鞗�)

鞚� 雮措秬鞛� 瓯半灅電� 鞚挫偓鞐� 雽�頃� 鞚检儊鞝侅澑 氤挫儊鞚� 雮橅儉雮措┌, 鞚挫偓須� 甑劚鞗� 欤检嫕 氤挫儊鞐� 甏�頃� 響滌 旮办梾 瓯半矂雱岇姢 甏�頄夓棎 攵�頃╉暕雼堧嫟.

Le directeur de CME Group, Martin J. Gepsman, a d茅clar茅 l'acquisition de 532 actions ordinaires de classe A le 25 juin 2025 au prix de 273,03 $ par action. Les actions ont 茅t茅 attribu茅es conform茅ment au Plan d'Actions des Directeurs de CME Group.

脌 la suite de cette transaction, Gepsman d茅tient d茅sormais directement un total de 25 299 actions. Le d茅p么t indique qu'il s'agissait d'une attribution standard de r茅mun茅ration pour directeur et non d'un achat sur le march茅 ouvert.

  • Type de transaction : Attribution d'actions (Code A)
  • Forme de propri茅t茅 : Directe
  • Statut du d茅p么t : D茅p么t individuel
  • R么le : Directeur (non salari茅)

Cette transaction d'initi茅 repr茅sente une r茅mun茅ration courante des directeurs et est conforme aux pratiques standard de gouvernance d'entreprise pour la r茅mun茅ration en actions des membres du conseil d'administration.

Der Direktor von CME Group, Martin J. Gepsman, meldete den Erwerb von 532 Aktien der Klasse A-Stammaktien am 25. Juni 2025 zu einem Preis von 273,03 $ pro Aktie. Die Aktien wurden im Rahmen des CME Group Director Stock Plans zugeteilt.

Nach dieser Transaktion besitzt Gepsman nun direkt insgesamt 25.299 Aktien. Die Meldung weist darauf hin, dass es sich um eine regul盲re Verg眉tung f眉r Direktoren handelte und nicht um einen Kauf am offenen Markt.

  • Transaktionstyp: Aktienzuteilung (Code A)
  • Form des Eigentums: Direkt
  • Meldeart: Einzelmeldung
  • Rolle: Direktor (nicht angestellt)

Diese Insider-Transaktion stellt eine routinem盲脽ige Verg眉tung f眉r Direktoren dar und entspricht den g盲ngigen Corporate-Governance-Praktiken f眉r die Aktienverg眉tung von Vorstandsmitgliedern.

Positive
  • None.
Negative
  • None.

Il direttore di CME Group, Martin J. Gepsman, ha riportato l'acquisizione di 532 azioni di azioni ordinarie di Classe A il 25 giugno 2025 al prezzo di 273,03 $ per azione. Le azioni sono state assegnate in base al Piano Azionario per i Direttori di CME Group.

A seguito di questa operazione, Gepsman possiede ora direttamente un totale di 25.299 azioni. La documentazione indica che si 猫 trattato di una normale assegnazione di compenso per direttori e non di un acquisto sul mercato aperto.

  • Tipo di transazione: Assegnazione di azioni (Codice A)
  • Forma di propriet脿: Diretta
  • Stato della comunicazione: Comunicazione individuale
  • Ruolo: Direttore (non dipendente)

Questa operazione interna rappresenta una compensazione ordinaria per i direttori e rispecchia le pratiche standard di governance aziendale per la remunerazione azionaria dei membri del consiglio.

El director de CME Group, Martin J. Gepsman, inform贸 la adquisici贸n de 532 acciones de acciones ordinarias Clase A el 25 de junio de 2025 a un precio de $273.03 por acci贸n. Las acciones fueron otorgadas conforme al Plan de Acciones para Directores de CME Group.

Tras esta transacci贸n, Gepsman posee ahora directamente un total de 25,299 acciones. El informe indica que se trat贸 de una concesi贸n est谩ndar de compensaci贸n para directores y no de una compra en el mercado abierto.

  • Tipo de transacci贸n: Premio en acciones (C贸digo A)
  • Forma de propiedad: Directa
  • Estado del reporte: Presentaci贸n individual
  • Rol: Director (no empleado)

Esta operaci贸n interna representa una compensaci贸n rutinaria para directores y est谩 en l铆nea con las pr谩cticas est谩ndar de gobernanza corporativa para la remuneraci贸n en acciones de los miembros del consejo.

CME 攴鸽９ 鞚挫偓 Martin J. Gepsman鞚� 2025雲� 6鞗� 25鞚�鞐� 韥措灅鞀� A 氤错喌欤� 532欤�毳� 欤茧嫻 $273.03鞐� 旆摑頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 頃措嫻 欤检嫕鞚� CME 攴鸽９ 鞚挫偓 欤检嫕 瓿勴殟鞐� 霐半澕 攵�鞐悳 瓴冹瀰雼堧嫟.

鞚措矆 瓯半灅 頉� Gepsman鞚� 歆侅爲鞝侅溂搿� 齑� 25,299欤�毳� 氤挫湢頃橁矊 霅橃棃鞀惦媹雼�. 鞝滌稖霅� 靹滊鞐� 霐半ゴ氅� 鞚措姅 瓿店皽 鞁滌灔鞐愳劀鞚� 毵れ垬臧� 鞎勲媽 鞚茧皹鞝侅澑 鞚挫偓 氤挫儊 攵�鞐榾鞀惦媹雼�.

  • 瓯半灅 鞙犿槙: 欤检嫕 氤挫儊 (旖旊摐 A)
  • 靻岇湢 順曧儨: 歆侅爲 氤挫湢
  • 鞁犼碃 靸來儨: 臧滌澑 鞁犼碃
  • 鞐暊: 鞚挫偓 (牍勳鞗�)

鞚� 雮措秬鞛� 瓯半灅電� 鞚挫偓鞐� 雽�頃� 鞚检儊鞝侅澑 氤挫儊鞚� 雮橅儉雮措┌, 鞚挫偓須� 甑劚鞗� 欤检嫕 氤挫儊鞐� 甏�頃� 響滌 旮办梾 瓯半矂雱岇姢 甏�頄夓棎 攵�頃╉暕雼堧嫟.

Le directeur de CME Group, Martin J. Gepsman, a d茅clar茅 l'acquisition de 532 actions ordinaires de classe A le 25 juin 2025 au prix de 273,03 $ par action. Les actions ont 茅t茅 attribu茅es conform茅ment au Plan d'Actions des Directeurs de CME Group.

脌 la suite de cette transaction, Gepsman d茅tient d茅sormais directement un total de 25 299 actions. Le d茅p么t indique qu'il s'agissait d'une attribution standard de r茅mun茅ration pour directeur et non d'un achat sur le march茅 ouvert.

  • Type de transaction : Attribution d'actions (Code A)
  • Forme de propri茅t茅 : Directe
  • Statut du d茅p么t : D茅p么t individuel
  • R么le : Directeur (non salari茅)

Cette transaction d'initi茅 repr茅sente une r茅mun茅ration courante des directeurs et est conforme aux pratiques standard de gouvernance d'entreprise pour la r茅mun茅ration en actions des membres du conseil d'administration.

Der Direktor von CME Group, Martin J. Gepsman, meldete den Erwerb von 532 Aktien der Klasse A-Stammaktien am 25. Juni 2025 zu einem Preis von 273,03 $ pro Aktie. Die Aktien wurden im Rahmen des CME Group Director Stock Plans zugeteilt.

Nach dieser Transaktion besitzt Gepsman nun direkt insgesamt 25.299 Aktien. Die Meldung weist darauf hin, dass es sich um eine regul盲re Verg眉tung f眉r Direktoren handelte und nicht um einen Kauf am offenen Markt.

  • Transaktionstyp: Aktienzuteilung (Code A)
  • Form des Eigentums: Direkt
  • Meldeart: Einzelmeldung
  • Rolle: Direktor (nicht angestellt)

Diese Insider-Transaktion stellt eine routinem盲脽ige Verg眉tung f眉r Direktoren dar und entspricht den g盲ngigen Corporate-Governance-Praktiken f眉r die Aktienverg眉tung von Vorstandsmitgliedern.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GEPSMAN MARTIN J
(Last) (First) (Middle)
20 S. WACKER DRIVE
(Street)
CHICAGO IL 60606
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CME GROUP INC. [ CME ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock Class A 06/25/2025 A(1) 532 A $273.03 25,299 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Granted pursuant to the CME Group Director Stock Plan, as amended and restated.
Remarks:
By: Jenelle Chalmers For: Martin J. Gepsman 06/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many CME Group shares did Director Martin Gepsman acquire on June 25, 2025?

According to the Form 4 filing, Director Martin J. Gepsman acquired 532 shares of CME Group Class A Common Stock on June 25, 2025 at a price of $273.03 per share.

What is Martin Gepsman's total CME stock ownership after the June 2025 transaction?

Following the reported transaction, Martin J. Gepsman beneficially owned 25,299 shares of CME Group Class A Common Stock directly (Form D).

How were the CME shares granted to Director Gepsman in June 2025?

The shares were granted pursuant to the CME Group Director Stock Plan, as amended and restated, as indicated in the footnotes of the Form 4 filing.

Who signed the Form 4 filing for CME Director Martin Gepsman?

The Form 4 was signed by Jenelle Chalmers on behalf of Martin J. Gepsman on June 26, 2025.

What is Martin Gepsman's role at CME Group according to the Form 4?

According to the Form 4 filing, Martin J. Gepsman serves as a Director of CME Group Inc., as indicated by the 'X' marked in the Director box under Section 5 (Relationship of Reporting Person to Issuer).
Stock CME logo
CME Group

NASDAQ:CME

CME Rankings

#183 Ranked by Market Cap
#1470 Ranked by Dividends

CME Latest News

Jul 23, 2025
CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q2 2025
Jul 22, 2025
CME Group and Nasdaq Extend Exclusive Nasdaq-100 Futures License Through 2039
Jul 10, 2025
CME Group International Average Daily Volume Hits Record 9.2 Million Contracts in Q2 2025, Up 18% Year over Year
Jul 2, 2025
CME Group Completes First Delivery Cycle of Hard Red Spring Wheat Futures
Jul 2, 2025
CME Group Sets Record Quarterly and June ADV, Driven by Growth Across Asset Classes

CME Latest SEC Filings

Jul 25, 2025
[8-K] CME Group Inc. Reports Material Event
Jul 23, 2025
[8-K] CME Group Inc. Reports Material Event
Jun 26, 2025
[Form 4] CME Group Inc. Insider Trading Activity
Jun 26, 2025
[Form 4] CME Group Inc. Insider Trading Activity
Jun 26, 2025
[Form 4] CME Group Inc. Insider Trading Activity

CME Stock Data

99.63B
358.67M
0.46%
89.89%
1.4%
Financial Data & Stock Exchanges
Security & Commodity Brokers, Dealers, Exchanges & Services
United States
CHICAGO